Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2087-2095
Published online before print April 14, 2008, doi: 10.1161/CIRCULATIONAHA.107.739227
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/16/2087    most recent
CIRCULATIONAHA.107.739227v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Westgate, E. J.
Right arrow Articles by FitzGerald, G. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westgate, E. J.
Right arrow Articles by FitzGerald, G. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Acute myocardial infarction
Right arrow Arterial thrombosis
Right arrow Genetics of cardiovascular disease
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrowRelated Article

(Circulation. 2008;117:2087-2095.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Genetic Components of the Circadian Clock Regulate Thrombogenesis In Vivo

Elizabeth J. Westgate, PhD; Yan Cheng, MD, PhD; Dermot F. Reilly, PhD; Tom S. Price, PhD; Jacqueline A. Walisser, PhD; Christopher A. Bradfield, PhD; Garret A. FitzGerald, MD

From the Institute for Translational Medicine and Therapeutics, School of Medicine, University of Pennsylvania, Philadelphia (E.J.W., Y.C., D.F.R., T.S.P., G.A.F.); and McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison (J.A.W., C.A.B.).

Correspondence to Garret A. FitzGerald, MD, 153 Johnson Pavilion, 3620 Hamilton Walk, Philadelphia, PA 19104. E-mail garret{at}spirit.gcrc.upenn.edu

Received September 10, 2007; accepted February 21, 2008.

Background— Myocardial infarction, stroke, and sudden death undergo diurnal variation. Although genes relevant to hemostasis and vascular integrity undergo circadian oscillation, the role of the molecular clock in thrombotic events remains to be established.

Methods and Results— A diurnal variation in the time to thrombotic vascular occlusion (TTVO) subsequent to a photochemical injury was observed in wild-type mice: TTVO varied from 24.6±2.7 minutes at zeitgeber time (ZT) 2 to 40.3±4.3 minutes at ZT8, 24.3±2.3 minutes at ZT14, and 31.0±4.4 minutes at ZT20. This pattern was disrupted or altered when core clock genes—BMAL1, CLOCK, and NPAS2—were mutated or deleted. Mutation of CLOCK abolished the diurnal variation in TTVO, whereas deletion of NPAS2 altered its temporal pattern. NPAS2 deletion prolonged TTVO and reduced blood pressure irrespective of clock time. Global BMAL1 deletion shortened TTVO at ZT8, and the diurnal variation in TTVO, but not in systemic blood pressure, was disrupted in mice in which BMAL1 had been selectively deleted in endothelium.

Conclusions— Key components of the molecular clock regulate the response to a thrombogenic stimulus in vivo. Such a phenomenon may interact with environmental variables, and together with the influence of these genes on blood pressure may contribute to the diurnal variation in cardiovascular events observed in humans.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 2041. [Full Text]